What impact do you think fully oral GLP-1 therapies could have on long-term patient adherence and accessibility
Reducing Cardiovascular Risk A recent study published in the prestigious New England Journal of Medicine showed that in heart failure patients with preserved ejection fraction and obesity, treatment with semaglutide (2.4 mg) led to greater reductions in symptoms, physical limitations, and weight loss than placebo
But the classic Zepbound was given with an auto-injector that patients could use at home
Current practice in the perioperative management of patients with diabetes mellitus: a narrative review
Online providers typically charge $199-$499 per month for compounded GLP-1 medications, which is significantly less than brand-name versions ($800-$1,500+/month)
This means contents, including archaea, are not properly moving through and out of the small intestine, potentially causing an increase in the number of bacteria or archaea (i.e